DermPro is a mobile application designed to support skin monitoring, skin health awareness and the understanding of information related to skin cancer risk.
The application may include features such as skin image assessment, skin type questionnaires, skin risk assessments, skin monitoring history, UV Index information, and educational resources about skin health.
This Instructions for Use document explains the intended purpose, operating requirements, functions, limitations, safety precautions and responsibilities associated with using DermPro.
Users should read these instructions before using the application and refer to them whenever necessary.
DermPro is a skin monitoring and informational support tool. It does not replace an examination by a qualified healthcare professional, a medical diagnosis or appropriate medical treatment.
DermPro is designed to support users in understanding and monitoring aspects of their skin health through digital skin assessment features, questionnaires, monitoring tools and educational information.
Depending on the available features and software version, the application may:
The application is intended to support monitoring and awareness. Its outputs are not a definitive determination of whether a skin lesion is benign, malignant or otherwise medically significant.
DermPro does not independently confirm the presence or absence of skin cancer. A healthcare professional must undertake an appropriate medical assessment when required.
DermPro is intended for members of the general public who wish to access skin health information and use available skin monitoring features.
Users should:
Where a user requires assistance with operating the application, a suitable support person may help with non-clinical activities, such as navigating the application or entering information with the user's permission.
DermPro is not intended to replace the professional responsibilities of dermatologists, general practitioners or other qualified healthcare professionals.
DermPro may be used by individuals who wish to:
The application may support users in becoming more aware of changes in their skin and understanding when further medical assessment may be appropriate.
DermPro must only be used for its stated intended purpose and within the limitations described in this document.
DermPro must not be used:
Important limitations:
Users should seek professional assessment whenever they notice a concerning skin change or have a medical concern, regardless of the application's output.
Users must follow the instructions provided within DermPro and this document.
Before using the application:
Users should not delay professional medical assessment because of an application result.
If a skin lesion is new, changing, bleeding, non-healing, painful or otherwise concerning, seek assessment from a qualified healthcare professional. Do not wait for a DermPro assessment before seeking care.
7.1 Warnings
7.2 Precautions
DermPro requires a compatible mobile device and supported operating system.
Depending on the device and available application functions, the requirements may include:
Users should refer to the official application store listing or the DermPro website for the latest supported devices and operating system requirements.
Application functionality may vary according to device compatibility, software version, internet availability and regional service availability.
To install DermPro:
Only install DermPro through authorised distribution channels.
Users should not install modified, unofficial or unauthorised versions of the application.
The available functions may vary depending on the application version and the user's location.
10.1 Account Access
10.2 Skin Type Assessment
The questionnaire provides an indication based on the responses entered. It does not constitute a medical examination or diagnosis.
10.3 Skin Risk Assessment
The assessment provides an indication based on the information entered. It does not establish whether an individual has or does not have skin cancer.
10.4 Skin Image Assessment
Where image assessment is available:
An image may be unsuitable for assessment if it is blurred, poorly illuminated, obstructed, incorrectly positioned or otherwise inconsistent with the application's image requirements.
Do not interpret an unsuccessful or inconclusive assessment as evidence that the skin feature is harmless.
10.5 Skin Monitoring History
Where the history feature is available:
A history of images or assessments can support personal awareness of skin changes. It does not replace a clinical examination or establish whether a change is medically significant.
10.6 UV Index Information
Where UV Index information is available:
UV Index information is provided to support general awareness of ultraviolet radiation exposure. It does not measure an individual's personal skin cancer risk or determine whether a particular level of sun exposure is safe for that individual.
10.7 Educational Information
Users may access educational information about skin health, skin cancer awareness, skin changes and prevention.
This information is provided for general educational purposes and should not be interpreted as an individual medical assessment or treatment recommendation.
DermPro may generate automated assessment outputs based on submitted images, questionnaire responses or other information processed by the application.
Users must understand the following:
Any risk indication or assessment category displayed by DermPro must be interpreted according to the specific explanation and limitations provided within the application.
Users should consult a qualified healthcare professional if they have concerns, notice skin changes or require further assessment.
DermPro may help users maintain records of previous skin assessments and images, where these features are available.
Users should:
DermPro does not determine the appropriate frequency of professional skin examinations unless such functionality has been specifically validated and authorised for that purpose.
Users should not postpone a medical appointment while waiting for an application assessment.
Skin cancer risk may be influenced by several factors, including:
DermPro may ask users to provide information relevant to available skin risk assessment functions.
Users should provide accurate and complete responses.
The information collected by the application may not represent every factor relevant to an individual's medical circumstances.
A risk indication generated by DermPro should not be treated as a comprehensive medical risk assessment or a prediction that an individual will or will not develop skin cancer.
If DermPro does not operate as expected:
For image assessment issues, users should also check that:
Do not attempt to modify the application or interfere with its operation.
If an error affects the reliability of an assessment, do not rely on the affected result.
DermPro may use automated image processing, algorithms or artificial intelligence, depending on the functionality of the installed version.
These technologies process submitted information according to the application's design and validated capabilities.
Their performance may be affected by:
Automated assessment systems cannot reproduce every aspect of a professional medical examination.
DermPro may not identify all suspicious skin features and may produce incorrect or inconclusive outputs.
The application must not be considered infallible.
The manufacturer should maintain appropriate documentation of software validation, algorithm performance, known limitations and relevant updates.
Users should report suspected application malfunctions, unexpected assessment outputs, technical problems or other safety-related concerns through the official DermPro support channel.
Where possible, reports should include:
Users should avoid including unnecessary sensitive personal or medical information in support requests.
The manufacturer should review reported problems, investigate potential safety concerns and take appropriate corrective action in accordance with applicable requirements in the markets where DermPro is supplied.
Where an incident may have caused or contributed to harm, the manufacturer must assess whether regulatory reporting obligations apply in the relevant jurisdiction.
Users should seek appropriate medical care independently of the application support process.
DermPro may collect, process, transmit or store information necessary to provide its available functions.
Depending on the application's design, this information may include:
Users should:
The manufacturer must implement appropriate technical and organisational safeguards to protect personal information against unauthorised access, disclosure, alteration, loss or misuse.
Specific information about data collection, processing, storage locations, retention periods, third-party sharing and deletion must be provided in the applicable Privacy Policy.
Users should review the DermPro Privacy Policy and applicable consent notices before submitting personal information or skin images.
Depending on the functions used, the application may process personal information and potentially sensitive health-related information.
The manufacturer must clearly explain:
Consent must be obtained where required by applicable privacy and data protection laws.
Users should not submit photographs containing unnecessary identifying information or images of another person without appropriate authority and consent.
The manufacturer may release application updates to improve functionality, usability, security, compatibility or assessment performance.
Users should:
Updates may change available features, technical requirements or assessment functions.
Changes that may affect the application's safety, intended purpose or assessment performance must be appropriately evaluated and managed by the manufacturer before release.
Users should not continue relying on a function that is displaying a known error or has been withdrawn.
DermPro provides digital skin monitoring functions, skin health information and automated assessment outputs within the scope of its stated intended purpose.
The application does not provide a definitive diagnosis of skin cancer and does not replace professional medical advice, examination, diagnosis or treatment.
Its outputs may be affected by technical limitations, image quality, user-provided information and the capabilities of the underlying software.
A reassuring result does not rule out skin cancer or another skin condition. A concerning result does not establish that a medical condition is present.
Users should seek advice from an appropriately qualified healthcare professional whenever they have concerns about their skin or notice new, changing or unusual skin features.
The application must not be used to delay necessary medical assessment or treatment.
Nothing in this document removes or limits any rights or protections that cannot lawfully be excluded under applicable consumer protection or other relevant laws.